Case Reports Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2021 Jun;27(4):996-999. doi: 10.1177/1078155220953877 Q41.02025

Alternative use of BRAF inhibitors in patients with metastatic melanoma unable to swallow pills

无法吞咽药片的转移性黑色素瘤患者中BRAF抑制剂的替代用法 翻译改进

作者单位 +展开

DOI: 10.1177/1078155220953877 PMID: 32878554

摘要 Ai翻译

Copyright © Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 中文内容为AI机器翻译，仅供参考！

相关内容

• Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors

  MC1R变异对BRAF抑制剂治疗的BRAF V600突变黑色素瘤患者预后的影响

  Michele Guida et al.

  Pigment cell & melanoma research. 2016 Nov;29(6):679-687.

• Overcoming metastatic melanoma with BRAF inhibitors

  BRAF抑制剂在治疗转移性黑色素瘤中的应用

  Seunghee Hong

  Archives of pharmacal research. 2011 May;34(5):699-701.

• Commentary: BRAF inhibitors for metastatic melanoma

  评论：转移性黑色素瘤的BRAF抑制剂治疗

  M Marples

  The British journal of dermatology. 2013 Mar;168(3):471-3.

• [Treatment of metastatic melanoma with BRAF inhibitors]

  BRAF抑制剂治疗转移性黑色素瘤

  C Hafner

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 2011 Sep;62(9):696-8.

• Patient-derived tumor xenograft model to guide the use of BRAF inhibitors in metastatic melanoma

  转移性黑色素瘤患者来源肿瘤异种移植模型指导使用BRAF抑制剂治疗

  Pierre Guerreschi et al.

  Melanoma research. 2013 Oct;23(5):373-80.

• Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use

  BRAF抑制剂与伊匹单抗治疗转移性黑色素瘤患者的顺序及临床应用算法研究

  Paolo A Ascierto et al.

  Journal of translational medicine. 2012 May 28:10:107.

• Left ventricular ejection fraction decrease related to BRAF and/or MEK inhibitors in metastatic melanoma patients: A retrospective analysis

  BRAF和/或MEK抑制剂治疗转移性黑色素瘤患者所致左心室射血分数下降的回顾性分析

  Mathilde Berger et al.

  Cancer medicine. 2020 Apr;9(8):2611-2620.

• Combination of BRAF Inhibitors and Brain Radiotherapy in Patients With Metastatic Melanoma Shows Minimal Acute Toxicity

  贝美替尼与脑放疗联合治疗转移性黑色素瘤患者毒性较低

  Natalia Rompoti et al.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Oct 20;31(30):3844-5.